Today: 9 June 2026
Browse Category

NASDAQ:FLEX 5 January 2026 - 6 June 2026

Campbell Soup heads for S&P 500 drop, earnings on deck

Campbell Soup heads for S&P 500 drop, earnings on deck

Campbell’s will be removed from the S&P 500 and added to the S&P SmallCap 600 before June 22, exposing shares to index-fund selling just as analysts expect lower Q3 sales and earnings; CPB rose 2.7% last week despite the broader market drop, but faces pressure from weak Snacks performance and a lowered 2026 outlook, with no Wall Street buy ratings and a $20.88 average price target below Friday’s $21.68 close.
6 June 2026
·····
Flex Enters S&P 500. Monday Trading Could Be Tricky

Flex Enters S&P 500. Monday Trading Could Be Tricky

Flex will join the S&P 500 on June 22, replacing Campbell’s, triggering index-fund buying; after falling 4.8% Friday, shares rose 1.5% post-announcement, as investors weigh index demand against a tech selloff and Flex’s AI data-center focus, with a planned Cloud and Power Infrastructure spinoff ahead.
6 June 2026
·
Flex grabs S&P 500 spot but shares drop

Flex grabs S&P 500 spot but shares drop

Flex will join the S&P 500 on June 22, drawing investor focus to its surging AI data-center power unit and planned spin-off, even as shares fell 4.8% to $151.92 amid a tech selloff; CPI sales jumped 38% to $6.61 billion in fiscal 2026, now 24% of total revenue, but margin slipped 100 basis points due to ramp-up costs and product mix.
6 June 2026
Flex AI Data Center Spin-Off: Why Shares Jumped Before the Bell

Flex AI Data Center Spin-Off: Why Shares Jumped Before the Bell

Flex will spin off its Cloud and Power Infrastructure unit as a separate public company, with CEO Revathi Advaithi set to lead the new entity, SpinCo. Flex shares jumped 28.4% premarket to $123.84 after reporting Q4 net sales of $7.5 billion, up 17%. SpinCo will target AI data center infrastructure, aiming for 65%-75% revenue growth in fiscal 2027. Key financial details and regulatory approvals remain undisclosed.
6 May 2026
·
Flex stock rises as AI data-center trade returns; eyes on May 13 Investor Day

Flex stock rises as AI data-center trade returns; eyes on May 13 Investor Day

Flex Ltd shares rose about 1% to $64.95 in early afternoon New York trading Wednesday, as chip and AI-linked stocks rallied. The stock traded between $63.58 and $66.24. Investors are watching for Flex’s next update on data-center power and cooling growth, with its Investor Day set for May 13 in Austin. Flex last reported quarterly net sales of $7.1 billion and repaid $597 million in notes due February 2026.
11 February 2026
·
Plexus stock jumps 7% in midday trade as contract manufacturers rally after CPI

Plexus stock jumps 7% in midday trade as contract manufacturers rally after CPI

Plexus Corp (PLXS) shares surged about 7% to $171.65 Tuesday, outpacing peers in a broad electronics manufacturing rally. The move followed a December inflation report showing consumer prices up 2.7% year-on-year. Analysts expect Plexus to report Q1 EPS near $1.77 on January 28. The stock now trades above the average analyst target of $159.
13 January 2026
····
Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet shares dropped 6.7% to $447.36 by early afternoon Monday, defying gains in the S&P 500 and Nasdaq. The decline came ahead of the company’s quarterly update, with investors watching for signs of demand shifts after management set a high revenue target for the December quarter. Jabil, Celestica, and Flex also fell. The ISM manufacturing PMI slipped to 47.9 in December, signaling contraction.
5 January 2026
·····

Stock Market Today

  • Washington's Railroad Rule Changes Threaten U.S. Supply Chain
    June 9, 2026, 9:15 AM EDT. Congress and the White House are quietly imposing new regulations on U.S. railroads, a critical component of the national economy. These changes, seen as micromanagement, could disrupt freight movement and supply chains. The timing raises concerns amid ongoing economic pressures and recovery efforts post-pandemic. Rail networks handle bulk goods and industrial materials vital to commerce. Industry experts warn that increased federal oversight may hinder operational efficiency and investment. Delays or inefficiencies in rail transport could ripple through markets, affecting costs and delivery times across sectors. Stakeholders urge a balanced approach to regulation to ensure infrastructure resilience without stifling rail companies' flexibility and growth.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Go toTop